Doctor profile · Federal record
Dr. Aparna Kalyan, MD
Hematology & Oncology Physician (CMS: Hematology/Oncology) · Student in an Organized Health Care Education/Training Program · Internal Medicine Physician · Chicago, IL
- NPI 1447482443
- Accepts Medicare
- MIPS 91.3 / 100 · 2023
- 21 yrs in practice
- Licensed in 3 states
- Female
- Group practice
- No sanctions
Practice & contact
- Primary practice
-
645 N Michigan Ave, Suite 1006
Chicago, IL 606112826
(312) 926-2000
Credentials & registration
- NPI registered
- August 2009 — 17 yrs on file
- Profile last updated
- August 8, 2014
- Year of graduation
- 2005 — 21 yrs since
- Specialty taxonomy
- 207RH0003X — NUCC code
- State licenses (3)
- Illinois #036136040 · Ohio #57.015832 · Pennsylvania #MD443729
Federal sanctions & exclusions
No sanctions, exclusions or revocations on file
Checked against OIG LEIE on NPI 1447482443. Last verified May 11, 2026.Medicare procedures · 2023
Top services delivered
Total services
33,494
Distinct HCPCS
10
Medicare allowed
$1,176,731
| HCPCS | Description | Services | Patients | Avg allowed | |
|---|---|---|---|---|---|
J9144 |
Injection, daratumumab, 10 mg and hyaluronidase-fihj | 9,360 | 36 | $48 | |
J1453 |
Injection, fosaprepitant, 1 mg | 5,100 | 25 | $0 | |
J9271 |
Injection, pembrolizumab, 1 mg | 4,000 | 18 | $54 | |
J1569 |
Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 3,200 | 32 | $45 | |
J9047 |
Injection, carfilzomib, 1 mg | 2,286 | 13 | $46 | |
J0897 |
Injection, denosumab, 1 mg | 2,040 | 17 | $24 | |
Q5107 |
Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg | 1,424 | 14 | $29 | |
J0461 |
Injection, atropine sulfate, 0.01 mg | 1,080 | 17 | $0 | |
J9041 |
Injection, bortezomib, 0.1 mg | 883 | 21 | $5 | |
J2469 |
Injection, palonosetron hcl, 25 mcg | 640 | 42 | $1 |
In context: peer comparison
Among 77 peers in Chicago Hematology & Oncology Physician, average services per provider: 870. This provider delivers 38× the peer median.Open Payments
Industry payments received
All-time total
$30,437
Transactions
14
Manufacturers
5
| Payer (manufacturer) | Industry | Txns | Amount |
|---|---|---|---|
| AstraZeneca Pharmaceuticals Lp | 7 | $14,342.45 | |
| Deciphera Pharmaceuticals INC. | 4 | $7,004.62 | |
| AstraZeneca Uk Limited | 1 | $6,850.00 | |
| E.R. Squibb & Sons, L.L.C. | 1 | $2,220.00 | |
| Ipsen Biopharmaceuticals, INC | 1 | $20.22 |
By nature of payment
Medicare Part D · 2023
Top prescriptions
Total claims
117
Patients
11
Total drug cost
$55,952
| Drug | Type | Claims | Patients | Total cost |
|---|---|---|---|---|
| Creon (Lipase/Protease/Amylase) | Brand | 19 | 0 | $54,512 |
| Gabapentin | Generic | 18 | 0 | $269 |
| Prochlorperazine Maleate | Generic | 17 | 11 | $233 |
| Midodrine Hcl | Generic | 15 | 0 | $207 |
| Amlodipine Besylate | Generic | 13 | 0 | $193 |
| Ondansetron Hcl | Generic | 12 | 0 | $68 |
| Venlafaxine Hcl | Generic | 12 | 0 | $246 |
| Pantoprazole Sodium | Generic | 11 | 0 | $222 |
Hospital affiliations
Frequently asked questions
What is Dr. Aparna Kalyan's medical specialty?
Dr. Aparna Kalyan practices Hematology & Oncology Physician in Chicago, IL.
Where does Dr. Aparna Kalyan practice?
Dr. Aparna Kalyan practices at 645 N Michigan Ave, Chicago, IL 606112826. Office phone: 3129262000.
What is Dr. Aparna Kalyan's NPI?
Dr. Aparna Kalyan's National Provider Identifier (NPI) is 1447482443, issued by NPPES.
Does Dr. Aparna Kalyan accept Medicare assignment?
Yes. Dr. Aparna Kalyan accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Aparna Kalyan commonly perform?
Top Medicare-reported procedures in 2023: Injection, daratumumab, 10 mg and hyaluronidase-fihj (HCPCS J9144); Injection, fosaprepitant, 1 mg (HCPCS J1453); Injection, pembrolizumab, 1 mg (HCPCS J9271). Source: CMS Medicare Physician & Other Practitioners file.